Parkinsonian syndrome in familial frontotemporal dementia
- PMID: 24998994
- PMCID: PMC4160731
- DOI: 10.1016/j.parkreldis.2014.06.004
Parkinsonian syndrome in familial frontotemporal dementia
Abstract
Parkinsonism in frontotemporal dementia (FTD) was first described in families with mutations in the microtubule-associated protein tau (MAPT) and progranulin (PRGN) genes. Since then, mutations in several other genes have been identified for FTD with parkinsonism, including chromosome 9 open reading frame 72 (C9ORF72), chromatin modifying protein 2B (CHMP2B), valosin-containing protein (VCP), fused in sarcoma (FUS) and transactive DNA-binding protein (TARDBP). The clinical presentation of patients with familial forms of FTD with parkinsonism is highly variable. The parkinsonism seen in FTD patients is usually characterized by akinetic-rigid syndrome and is mostly associated with the behavioral variant of FTD (bvFTD); however, some cases may present with classical Parkinson's disease. In other cases, atypical parkinsonism resembling progressive supranuclear palsy (PSP) or corticobasal syndrome (CBS) has also been described. Although rare, parkinsonism in FTD may coexist with motor neuron disease. Structural neuroimaging, which is crucial for the diagnosis of FTD, shows characteristic patterns of brain atrophy associated with specific mutations. Structural neuroimaging is not helpful in distinguishing among patients with parkinsonian features. Furthermore, dopaminergic imaging that shows nigrostriatal neurodegeneration in FTD with parkinsonism cannot discriminate parkinsonian syndromes that arise from different mutations. Generally, parkinsonism in FTD is levodopa unresponsive, but there have been cases where a temporary benefit has been reported, so dopaminergic treatment is worth trying, especially, when motor and non-motor manifestations can cause significant problems with daily functioning. In this review, we present an update on the clinical and genetic correlations of FTD with parkinsonism.
Keywords: Autosomal dominant; Familial; Frontotemporal dementia; Genetics; Mutation; Parkinsonism.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
JS is supported by the Stowarzyszenie na Rzecz Rozwoju Neurologii Wieku Podeszlego grant.
SF is supported by a gift from Carl Edward Bolch, Jr. and Susan Bass Bolch.
ZKW is partially supported by NIH/NINDS P50 NS072187, and a gift from Carl Edward Bolch, Jr. and Susan Bass Bolch.
Similar articles
-
Parkinsonism, movement disorders and genetics in frontotemporal dementia.Nat Rev Neurol. 2016 Mar;12(3):175-85. doi: 10.1038/nrneurol.2016.14. Epub 2016 Feb 19. Nat Rev Neurol. 2016. PMID: 26891767 Review.
-
Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.Neurobiol Aging. 2017 May;53:195.e11-195.e17. doi: 10.1016/j.neurobiolaging.2017.02.002. Epub 2017 Feb 10. Neurobiol Aging. 2017. PMID: 28268100 Free PMC article.
-
Frontotemporal dementia: implications for understanding Alzheimer disease.Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006254. doi: 10.1101/cshperspect.a006254. Cold Spring Harb Perspect Med. 2012. PMID: 22355793 Free PMC article. Review.
-
Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia.Neurobiol Aging. 2016 Oct;46:235.e11-5. doi: 10.1016/j.neurobiolaging.2016.05.013. Epub 2016 May 20. Neurobiol Aging. 2016. PMID: 27311648
-
Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.CNS Drugs. 2012 Oct 1;26(10):841-70. doi: 10.2165/11640070-000000000-00000. CNS Drugs. 2012. PMID: 22950490 Review.
Cited by
-
Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins.Int J Mol Sci. 2024 Aug 1;25(15):8399. doi: 10.3390/ijms25158399. Int J Mol Sci. 2024. PMID: 39125972 Free PMC article.
-
Modeling Parkinson's Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells.Int J Mol Sci. 2018 Dec 4;19(12):3870. doi: 10.3390/ijms19123870. Int J Mol Sci. 2018. PMID: 30518093 Free PMC article. Review.
-
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia.Brain Commun. 2023 Feb 17;5(2):fcad036. doi: 10.1093/braincomms/fcad036. eCollection 2023. Brain Commun. 2023. PMID: 36938528 Free PMC article.
-
Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes.J Alzheimers Dis. 2022;89(4):1221-1231. doi: 10.3233/JAD-220272. J Alzheimers Dis. 2022. PMID: 35988220 Free PMC article.
-
The Frequency of Genetic Mutations Associated With Behavioral Variant Frontotemporal Dementia in Chinese Han Patients.Front Aging Neurosci. 2021 Jul 8;13:699836. doi: 10.3389/fnagi.2021.699836. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34305575 Free PMC article.
References
-
- Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D’Amato CJ, Gilman S. Conference Participants. Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A Consensus Conference. Ann Neurol. 1997;41:706–715. - PubMed
-
- Puschmann A. Monogenic Parkinson’s disease and parkinsonism: Clinical phenotypes and frequencies of known mutations. Parkinsonism and Related Disorders. 2013;19:407–415. - PubMed
-
- Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IR, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73:1451–1456. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous